Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
 
Home
 
Registration
Keynote Speakers (TBA)
Industry Panel Discussion (TBA)

 

Invest, Partner and Network with the Most Promising Early- to Late-Stage Medical Technology Companies and the Biggest Deal Makers in the Medtech Business Development and Investment Communities

REGISTER TODAY!

For more information, please contact Kristy Grimes at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com

Program Benefits:

  • Hear presentations from 50+ promising early-stage device companies, each followed by one-on-one meetings in private breakout rooms
  • Network with 250+ key deal makers in the device and investment communities
  • Gain valuable, actionable insight with plenary sessions by device industry thought leaders sharing their in-the-trenches experiences in building, funding and selling their companies
  • Get a head start on 2008 with a Manufacturer Perspective panel discussion/case study: What Are Buyers Looking for in 2008?
  • Learn from a Venture Perspective panel discussion/case study: Doing Innovative or Unconventional Deals
  • Workshops

… and much, much more!

Presentations from our hand-selected group of cutting-edge, early-stage companies will encompass a wide variety of high-growth device sectors, including:

  • Cardiovascular Therapeutics and Diagnostics/Interventional Cardiology
  • Diagnostics
  • Drug Delivery
  • Imaging
  • Minimally Invasive Surgery
  • Nanotechnology
  • Neurostimulation
  • Oncology
  • Orthopedics/Spine
  • Peripheral Vascular
  • Stem Cells
  • Stroke Management
  • Tissue Engineering
  • Wound Management

... to mention only a few.
Advisory Board

Jeffrey Barnes
General Partner
Oxford Bioscience Partners

Annette Campbell-White
Senior Managing Member MedVenture Associates

Michael Carusi
General Partner
Advanced Technology Ventures

Luke Evnin
General Partner
MPM Capital

Richard M. Ferrari
Managing Director
DeNovo Ventures

William T. Harrington
Partner
Three Arch Partners

Ross A. Jaffe
Managing Director
Versant Ventures

Ellen Koskinas
Partner
InterWest Partners

Josh Makower
Venture Partner
NEA

John Maroney
General Partner
Delphi Ventures

David Milne
Managing Partner
SV Life Science Advisers

Trevor J. Moody
Partner
Frazier Healthcare Ventures

Jesse I Treu
Partner
Domain Associates
back to top

Presenting Companies

Presenting Companies
Locations		 Technologies
ACell, Inc.
Columbia, MD 		(technology description coming soon)
Advanced Headache Intervention (First-Time Presenter)
Centennial, CO 		Minimally invasive surgical device for RF nerve ablation resulting in reduction of migraine headache pain.
Angel Medical Systems (First-Time Presenter)
Shrewsbury, NJ 		An implantable cardiac monitoring and patient alerting system for ischemic events to reduce time to treatment.
Ascension Technology (First-Time Presenter)
Milton, VT 		DC magnetic tracking technology for 3D guidance of medical tools in image-guided procedures.
Bone Biologics, Inc.
Thousand Oaks, CA 		(technology description coming soon)
Cardiva Medical, Inc.
Mountain View, CA 		Percutaneous Access Management System provides early ambulation, eliminates major complications, leaves nothing behind in patient
Ceragenix Pharmaceuticals (First-Time Presenter)
Denver, CO 		Medical device related hospital infections are responsible for over 50,000 deaths, increased hospital stays and billions of dollars of added costs. Ceragenix Pharmaceuticals is developing its "Cerashield" line of antimicrobial coatings to prevent microbial colonization and biofilm formation of endotracheal tubes and other indwelling medical devices.
Cohera Medical, Inc. (First-Time Presenter)
Pittsburgh, PA 		Cohera Medical is developing TissuGlu™, a biodegradable surgical adhesive for seroma reduction in plastic surgery
CoreSpine Technologies
Minneapolis, MN 		CoreSpine will prepare the spinal disc for a nucleus replacement or minimally invasive fusion device.
Crospon (First-Time Presenter)
Galway, Ireland 		EndoFLIP™ technology for real-time assessment of gastroesophageal junction competence used to determine suitability for and outcome of Anti-Reflux Surgery.
CVAC Systems, Inc.
Temecula, CA 		Non-invasive metabolic enhancement reduces LDL cholesterol, increases testosterone, and improves hemoglobin A1C in diabetics
Deca-Medics, Inc. (First-Time Presenter)
Columbus, OH 		revolutionary device for the treatment of Sudden Cardiac Arrest for both in and out of the hospital markets.
DermTech International (First-Time Presenter)
LaJolla, CA 		DermTech is developing non-invasive molecular diagnostics for the early detection of melanoma and other diseases, theranostics and drug development.
eCardio Diagnostics
The Woodlands, TX 		eCardio Diagnostics, www.eCardio.com, is the leading North American provider of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring, and subsequent clinical management of cardiac arrhythmias.
EMKinetics (First-Time Presenter)
San Francisco, CA 		EMKinetics is a medical device company focused on using a patented system for therapeutic nerve stimulation to treat urinary incontinence (UI) and overactive bladder (OAB).
HealthLink Europe
Raleigh, NC 		HealthLink Europe is an ISO 13485 certified Medical Device Distribution Company with facilities in The Netherlands, assisting emerging American Medical device companies to grow in Europe.
HemoBioTech
Dallas, TX 		Revolutionary Red Blood Cell Substitute that is Vasodilatory, Anti-inflammatory, and induces Erythropoiesis (red blood cell production).
Infrared Sciences Corporation (First-Time Presenter)
Stony Brook, NY 		FDA Cleared non-invasive infrared imaging system for the early detection of breast cancer.
Innovent Medical Solutions, Ltd.
Jerusalem, Israel 		Non-invasive airway clearance in ICU patients to prevent Ventilator Associated Pneumonia.
Interventional and Surgical Innovations, LLC (First-Time Presenter)
Campbell Hall, NY 		Introducing Four Medical Devices:
1. Inferior Vena Cava Filter designed for temporary and or permanent placement with truly unique features including the ability to accurately reposition the filter, during placement, when desired.
2. ISI is developing a Percutaneous Venous Valve for the replacement of incompetent deep vein valves in patients with Chronic Venous Insufficiency, a condition affecting millions of people worldwide.
3. Interventional procedures require multiple guidewire exchanges that take valuable time and add possible complications to critical procedures. ISI is developing a guidewire that is essentially 3 guidewires in one reducing valuable time and eliminating frustrating exchanges.
4. Laparoscopic hand instrument designed to reduce operating time and reduce time and risks from instrument exchanges complementing any laparoscopic instrument set.
Light Sciences Oncology
Snoqualmie, WA 		Litx uses LEDs to activate LS11 (talaporfin sodium), producing singlet oxygen that can kill target tumor cells.
Med-Conduit, Inc. (First-Time Presenter)
Tewksbury, MA 		Med-Conduit is an innovative medical device company, in developmental stage, focused on infection control in patients who have received a catheter, feeding tube, or other percutaneous access device (PAD) as part of the treatment of their disease.
Micronics (First-Time Presenter)
Redmond, WA 		Micronics is a leading developer of microfluidics; enables near-patient, point-of-care molecular testing for rapid diagnosis of infectious disease.
Minnow Medical
San Diego, CA 		New Catheter technology to treat artery disease now in clinical studies.
mNemoscience GmbH
Aachen, Germany 		mNemoscience is pioneering the design and manufacture of innovative biocompatible shape memory polymers (BIO-SMP) which can be programmed to change shapes and rigidity when an initiating stimulus, such as e.g. change in temperature, is applied. Further programmable key features are varying rates of biodegradation and outstanding mechanical properties which overcome the material limitations of other materials.
Moerae Matrix, Inc. (First-Time Presenter)
West Lafayette, IN 		Development-stage tissue-engineering company developing novel approaches to prevent abnormal tissue growth inhibiting surgical procedure recovery.
Navigant Biotechnologies, LLC (First-Time Presenter)
Lakewood, CO 		Navigant's devices use riboflavin and light to inactivate leukocytes and pathogens in donated blood products.
NeoMend, Inc.
Irvine, CA 		NeoMend is a biomaterials company commercializing advanced wound management products based upon its proprietary polymer hydrogel technology.
Nerites Corporation
Madison, WI 		Water resistant adhesives derived from mussels used as tissue adhesives and anti-bacterial coatings
Nesos Health Inc.
St. Paul, MN 		A product to deliver electromagnetic thermal therapy to relieve pain and improve function in patients suffering from osteoarthritis.
Novian Health Inc. (First-Time Presenter)
Chicago, IL 		A minimally-invasive procedure for ablation of breast tumors offering minimal scarring, quicker recovery times, and only requiring local anesthesia.
Ortho Kinematics (First-Time Presenter)
San Francisco, CA 		A tool for better diagnosing spine function to improve outcomes for spine fusion & arthroplasty surgery.
Photo Dynamic Therapy
Vienna, Austria 		“Plug&play”-system to treat non-invasively curative and palliative tumors and precursors specific to patients’ individual need.
PolyRemedy, Inc. (First-Time Presenter)
Mountain View, CA 		a point-of-care robotic system for on-demand fabrication of nano-material based wound care dressings.
Portland Orthopaedic (First-Time Presenter)
Matraville, NSW, Australia 		Fully modular total hip replacement systems to reduce wear and add longevity.
Provista Life Sciences, LLC
Phoenix, AZ 		The BT Test, a blood test for breast cancer, is offered through Provista Diagnostics, a CLIA Reference Lab
Seno Medical Instruments, Inc.
San Antonio, TX 		A platform technology using Opto-Acoustics for functional imaging and cancer diagnosis.
STI Medical Systems (First-Time Presenter)
Honolulu, HI 		Development and commercialization of Virtual BiopsyR imaging systems software for minimally invasive cancer detection.
Sunshine Heart Company Pty Ltd (First-Time Presenter)
Tustin, CA 		Cardiac assist device to treat patients in moderate to severe long term heart failure.
ThermopeutiX, Inc. (First-Time Presenter)
San Diego, CA 		Catheter-based systems that will provide very rapid and selective hypothermia to various body organs and locations.
Tissue Genetics (First-Time Presenter)
Boulder, CO 		Tissue Genetics is a predictive medicine company with novel technology for diagnosing breast and ovarian cancer and determining responsiveness to new therapeutics.
Ultimate Spine (First-Time Presenter)
Newport Beach, CA 		Ultimate Spine provides the surgeon with a truly minimally invasive or open system. Utilizing a proprietary uni-axial screw at one half the costs of poly axial systems. We treat all disorders both posterior and anterior from the Sacrum to the Occipital plate.
ValveXchange
Lakespur, CO 		A medical device company developing a bioprosthetic heart valve with a percutaneously-exchangeable leaflet set that provides lifetime service without anti-coagulation therapy.
VeinAid, LLC (First-Time Presenter)
Fairfield, CT 		Non-invasive devices for the treatment of superficial venous disease.
Veran Medical (First-Time Presenter)
Nashville, TN 		Veran Medical Technologies is developing medical devices that enable earlier detection and minimally invasive treatment of lung cancer.
Victhom Human Bionics, Inc.
Quebec, Canada 		Human bionic devices that can instantaneously interact with the human body to replace or restore biomechanical or physiological functions
Visualase, Inc. (First-Time Presenter)
Houston, TX 		MRI-guided laser ablation system for targeted, minimally invasive, focal tumor therapy.
Vivoxid, Ltd. (First-Time Presenter)
Turku, Finland 		Vivoxid is a global developer of medical nanotech surfaces & biocompatible resorbable biomaterials.
Xylos Corporation
Langhorne, PA 		Biocellulose technology for the treatment, repair, and replacement of human tissue that eliminates the risks, complications and limitations inherent in animal, human and synthetic biomaterials
Zassi Medical Evolutions, Inc.
Fernandina Beach, FL 		Zassi is developing a breakthrough system of products that will restore continence control to individuals with abdominal ostomies and eventually, eliminate the need for the traditional ostomy pouching systems.
 

Benefits of Attending:

  • Potential acquirers/funding partners will able to meet and screen over 50 first-rate investment possibilities in just 2 well-orchestrated days, via focused presentations covering their widely varied technologies, stage of development and testing, potential markets, management teams, regulatory timeline, patent protection, competitive strategy, funding needed, among many other key details, and private break-out sessions, among many other networking opportunities.
  • It’s a fact that medical device start-ups face intense competition for a finite amount of available capital funding: In3 West Las Vegas is an ideal setting for emerging company management teams to meet and impress potential investors, from many of the heavy-hitting, top-tier device companies and discerning healthcare investment firms from around the world.
  • All attendees will gain a keen understanding in a short timeframe of the emerging medical technologies on course to make a distinct impact on the intensely competitive and evidence-driven device industry in the next few years. Register to attend today and get ready to tap into the many opportunities about to emerge in the medtech space!


In3 West Las Vegas is Medtech Insight and Windhover Information’s 29th In3 event – find out for yourself why these first-rate events are considered the most important venue of their kind for key investors interested in the medical device space.

We have a long and strong track record: Over 1300 emerging medical technology company presenters and over 7000 attendees have participated at In3 events over the past 6 years. We are very proud that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at In3 events. Click here for success stories and testimonials from our past presenters and attendees.

Attendees will include:

  • Presidents
  • CEOs
  • Chairmen
  • Venture Partners
  • Managing Directors
  • Vice Presidents/Directors of Business Development, Marketing, New Technology, Acquisitions, R & D & Sales
  • Senior Investment Analysts/Managers/Directors

…. from these types of companies:

  • Established medical technology companies seeking technology through licensing, partnering and acquisition to broaden or deepen product lines or build sector strength
  • Venture capitalists and investment bankers, and
  • Medical device, biotech, biopharmaceutical or other company executives seeking investments or partnerships

The med device industry is red hot, with the number of deals now increasing each year. In3 West Las Vegas is a do-not-miss event for anyone interested in the best-of-the-best emerging medtech companies: we are expecting a record number of participants, from both the buy and sell side – hurry and secure your spot today!
back to top

Program Agenda

February 27, 2008
6:00 - 8:00 PM Pre-Conference Reception/Registration - Marco Polo 801 (Level 1)
Pre-Conference Workshop Marco Polo 701 & 702 (Level 1)
7:00 - 8:00 PM Pre-Conference Workshop
10 Things Every Medical Technology Entrepreneur Should Know
Presented by Chris Velis, Chairman and CEO, Medical Capital Advisors
February 28, 2008
7:00 - 8:00 AM Registration & Continental Breakfast - Marco Polo 801-802 (Level 1)
8:00 - 8:10 AM Welcome/Opening - Marco Polo 701-703 (Level 1)
8:10 - 9:25 AM Panel Discussion
Venture Perspective panel discussion/case study: Doing Innovative or Unconventional Deals

David Cassak, Manging Partner, Windhover Information (moderator)

Ellen Koskinas, Partner, InterWest Partners

Kurt C. Wheeler, Managing Director, Clarus Ventures

Maurice Werdegar, Investment Partner, Western Technology Investment

Samuel Wu, MD, PhD, Principal, SV Life Sciences
9:35 - 9:40 AM Moderator - MedMarc & The Hartford
9:40 - 9:50 AM Xylos Corporation
9:50 - 10:00 AM Nesos Health Inc.
10:00 - 10:10 AM ISI Guidewire
10:10 - 10:20 AM CoreSpine Technologies
10:20 - 10:30 AM Provista Life Sciences, LLC
10:30 - 10:40 AM Infrared Sciences Corporation
10:40 - 10:50 AM Light Sciences Oncology
10:55 - 11:00 AM Moderator - The Medtech Group
11:00 - 11:10 AM eCardio Diagnostics
11:10 - 11:20 AM Photo Dynamic Therapy
11:20 - 11:30 AM Portland Orthopaedic
11:30 - 11:40 AM ValveXchange
11:40 - 11:50 AM Innovent Medical Solutions, Ltd.
11:50 - 12:00 PM Tissue Genetics
12:00 - 12:10 PM Advanced Headache Intervention
12:10 - 12:20 PM Ascension Technology
12:20 - 12:30 PM Veran Medical
12:30 - 1:30 PM Networking Lunch Marco Polo 704-706 (Level 1)
1:30 - 1:35 PM Moderator - Battelle
1:35 - 1:45 PM ISI Percutaneous Venous Valve
1:45 - 1:55 PM Ortho Kinematics
1:55 - 2:05 PM DermTech International
2:05 - 2:15 PM EMKinetics Inc.
2:15 - 2:25 PM Moerae Matrix, Inc.
2:25 - 2:35 PM Deca-Medics, Inc.
2:40 - 2:45 PM Moderator - Curran International
2:45 - 2:55 PM Ceragenix Pharmaceuticals
2:55 - 3:05 PM Vivoxid, Ltd.
3:05 - 3:15 PM Cohera Medica, Inc.
3:15 - 3:25 PM Angel Medical Systems
3:25 - 3:35 PM mNemoscience GmbH
3:35 - 3:45 PM Ultimate Spine
3:45 - 3:55 PM Minnow Medical
3:55 - 4:05 PM Crospon
4:05 - 4:10 PM Moderator - Medical Capital Advisors
4:10 - 4:20 PM ThermopeutiX, Inc.
4:20 - 4:30 PM PolyRemedy, Inc.
4:30 - 4:40 PM HemoBioTech
4:40 - 4:50 PM Med-Conduit, Inc.
4:50 - 5:00 PM Seno Medical Instruments, Inc.
5:00 - 5:10 PM Nerites Corporation
5:10 - 5:20 PM ACell, Inc.
5:20 - 5:30 PM Novian Health Inc.
5:30 - 5:55 PM Sponsor-Supported Networking Session Marco Polo 801-802 (Level 1)
5:55 - 7:25 PM Presenting Company Exhibition/Networking Reception Marco Polo 704-706 (Level 1)
February 29, 2008
7:30 - 8:10 AM Registration & Continental Breakfast - Marco Polo 801-802
8:10 - 8:15 AM Welcome/Opening - Marco Polo 701-703
8:15 - 9:15 AM Panel Discussion
Buyers' Perspective Panel Discussion/Case Study
What Are Buyers Looking for In 2008?

Chad Cornell, Director of Corp Development, Medtronic

Dr. Ryan Harris, MD, Principal, The Carlyle Group


Panel Topics:

- What is your current philosophy/approach to investments?

- What role does M&A Play?

- What do you believe is the success rate of device M&A deals?

- What technology/therapeutic areas are currently of particular interest?

- In looking for M&A opportunities, how often do you look for technologies outside of your primary clinical spaces?

- Small companies are always interested in learning the best ways to get in touch with potential acquirers. What is the best way for a start-up to reach out to J&J? Do you like companies to contact you directly or do you prefer to make the contacts yourself?

- At what stage of product development do you like to make contacts with companies?

- Can you offer small companies some do's and don'ts of dealmaking negotiations?

- At what point in the discussion is it appropriate to begin to talk to companies about valuation and do you provide guidelines in terms of how you value companies?

- How much does competitive pressure contribute to driving up deal prices, and does that increase when other large potential acquirers are involved in the bidding?

- Are there enough venture-backed small companies in the pipeline so that you're satisfied that you're seeing a robust flow of opportunities?
9:15 - 9:20 AM Moderator - The Medtech Group
9:20 - 9:30 AM Cardiva Medical, Inc.
9:30 - 9:40 AM ISI Scissor Grasper
9:40 - 9:50 AM NeoMend, Inc.
9:50 - 10:00 AM Zassi Medical Evolutions, Inc.
10:00 - 10:10 AM Sunshine Heart Company Pty Ltd
10:10 - 10:20 AM Victhom Human Bionics, Inc.
10:25 - 10:30 AM Moderator - MedMarc & The Hartford
10:30 - 10:40 AM HealthLink Europe
10:40 - 10:50 AM VeinAid, LLC
10:50 - 11:00 AM Bone Biologics, Inc.
11:00 - 11:10 AM ISI Vena Cava Filter
11:15 - 11:20 AM Moderator - TATRC
11:20 - 11:30 AM STI Medical Systems
11:30 - 11:40 AM Navigant Biotechnologies
11:40 - 11:50 AM Micronics
11:55 - 12:00 PM Moderator - AdvaMed
12:00 - 12:10 PM Visualase, Inc.
12:10 - 12:20 PM CVAC Systems, Inc.
12:20 - 1:00 PM Box Lunch & Adjournment

 

*Cancellation Policy: The last day to cancel your registration for a refund, minus a $300 processing fee, is January 25, 2008. After that, you may send another delegate from your company


Sponsored by:

Financial Contributor: